BACKGROUND: The autonomic nervous system (ANS) is a key regulator of the cardiovascular system. The two arms of the ANS, sympathetic and parasympathetic (vagal) have co-regulatory effects on cardiac homeostasis. ANS modulation and dysfunction are also believed to affect various cardiac disease states. Over the past decade, there has been increasing evidence suggesting gender differences in ANS activity. METHODS: In multiple previous studies, ANS activity was primarily assessed using heart rate variability, muscle sympathetic nerve activity, coronary blood flow velocity, and plasma biomarkers. Heart rate variability is a non-invasive measure, which can be analyzed in terms of low frequency and high frequency oscillations, which indicate the sympathetic and parasympathetic tone, respectively. These measures have been studied between women and men in states of rest and stress, and in cardiac disease. CONCLUSION: Studies support the concept of a significant gender difference in ANS activity. Further studies are indicated to elucidate specific differences and mechanisms, which could guide targeted therapy of various cardiovascular disease states.
BACKGROUND: The autonomic nervous system (ANS) is a key regulator of the cardiovascular system. The two arms of the ANS, sympathetic and parasympathetic (vagal) have co-regulatory effects on cardiac homeostasis. ANS modulation and dysfunction are also believed to affect various cardiac disease states. Over the past decade, there has been increasing evidence suggesting gender differences in ANS activity. METHODS: In multiple previous studies, ANS activity was primarily assessed using heart rate variability, muscle sympathetic nerve activity, coronary blood flow velocity, and plasma biomarkers. Heart rate variability is a non-invasive measure, which can be analyzed in terms of low frequency and high frequency oscillations, which indicate the sympathetic and parasympathetic tone, respectively. These measures have been studied between women and men in states of rest and stress, and in cardiac disease. CONCLUSION: Studies support the concept of a significant gender difference in ANS activity. Further studies are indicated to elucidate specific differences and mechanisms, which could guide targeted therapy of various cardiovascular disease states.
Authors: Daniel N Pugliese; John N Booth; Luqin Deng; D Edmund Anstey; Natalie A Bello; Byron C Jaeger; James M Shikany; Donald Lloyd-Jones; Cora E Lewis; Joseph E Schwartz; Paul Muntner; Daichi Shimbo Journal: J Hypertens Date: 2019-12 Impact factor: 4.844
Authors: Michelle M Monasky; Carlo Pappone; Marco Piccoli; Andrea Ghiroldi; Emanuele Micaglio; Luigi Anastasia Journal: Front Physiol Date: 2018-08-10 Impact factor: 4.566
Authors: Daniela Litscher; Junying Wang; Gerhard Litscher; Guangzong Li; Peggy Bosch; Maurits van den Noort; Lu Wang Journal: Medicines (Basel) Date: 2018-03-15
Authors: Charikleia Stefanaki; Athanasios Michos; George Latsios; Dimitrios Tousoulis; Melpomeni Peppa; Paraskevi Zosi; Dario Boschiero; Flora Bacopoulou Journal: Int J Environ Res Public Health Date: 2020-04-14 Impact factor: 3.390
Authors: William R Tebar; Raphael M Ritti-Dias; Jorge Mota; Breno Q Farah; Bruna T C Saraiva; Tatiana M M Damato; Leandro D Delfino; Beatriz A S Aguilar; Amanda B Dos Santos; Stefany C B Silva; Luiz Carlos M Vanderlei; Diego G D Christofaro Journal: Sci Rep Date: 2020-09-23 Impact factor: 4.379